Zusätzlich wurden 32 Hybrid-DRG-Fälle erbracht: L17N 4 L20M 19 L20N 9
Services search (in the department)
| Illness | Number of cases |
|---|---|
| Hyperplasia of prostate (N40) | 36 |
| Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | 33 |
| Malignant neoplasm of prostate (C61) | 30 |
| Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) | 17 |
| Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) | 17 |
| Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) | 14 |
| Neoplasm of uncertain or unknown behaviour of male genital organs - Neoplasm of uncertain behavior of prostate (D40.0) | 10 |
| Other disorders of urinary system - Urinary tract infection site not specified (N39.0) | 10 |
| Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5) | 8 |
| Other disorders of bladder - Bladder-neck obstruction (N32.0) | 6 |
| Treatment | Number |
|---|---|
| Injection or administration of medicines into the urinary bladder (8-132.3) | 149 |
| Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 90 |
| X-rays of the kidney and urinary tract with contrast medium (3-13d.5) | 42 |
| Dilatation of the ureters during an operation or endoscopy (5-560.2) | 41 |
| (5-98k.0) | 38 |
| Insertion, exchange or removal of a ureteral stent (8-137.00) | 32 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) | 31 |
| Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) | 31 |
| Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.1) | 27 |
| Injection or administration of medicines into the urinary bladder (8-132.2) | 25 |
Department key: 2200
Inpatient department
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | 0 |
| No. | Explanation |
|---|---|
| CQ31 |
| Number | Group |
|---|---|
| 52 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 33 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 29 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB19 | Nursing professionals | Dreijährig examiniertes Pflegepersonal |
| HB17 | Auxiliary nurse (m/f) | Einjährig examiniertes Pflegepersonal |
Herr Michael Hofmann
Klinikgeschäftsführer
Phone:
09372
-700-1000
Mail:
ed.tiehdnuseg-soileh@2nnamfoH.leahciM
Frau Natascha Breunig
Qualitätsmanagement
Phone:
09372
-700-1065
Mail:
ed.tiehdnuseg-soileh@hcabnelrE.gnunieM
Frau Natascha Breunig
Qualitätsmanagementbeauftragte
Phone:
09372
-700-1065
Mail:
ed.tiehdnuseg-soileh@ginuerB.ahcsataN
Ärztlicher Direktor / Herr Chefarzt Dr. Michael Weberpals
Vorsitzender
Phone:
09372
-700-1920
Mail:
ed.tiehdnuseg-soileh@slaprebeW.leahciM
Frau Susana Höll Jordao
kommissarische Leitung Apotheke
Phone:
0611
-43-3515
Mail:
ed.tiehdnuseg-soileh@oadroJlleoH.anasuS